HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system.

Abstract
The nociceptin receptor (NOP) and its ligand nociceptin/orphanin FQ (N/OFQ) have been shown to exert a modulatory effect on immune cells during sepsis. We evaluated the suitability of an experimental lipopolysaccharide (LPS)-induced sepsis model for studying changes in the nociceptin system. C57BL/6 mice BALB/c mice and Wistar rats were inoculated with different doses of LPS with or without a nociceptin receptor antagonist (UFP-101 or SB-612111). In C57BL/6 mice LPS 0.85 mg/kg injection produced no septic response, whereas 1.2mg/kg produced a profound response within 5h. In BALB/c mice, LPS 4 mg/kg produced no response, whereas 7 mg/kg resulted in a profound response within 24h. In Wistar rats LPS 15 mg/kg caused no septic response in 6/10 animals, whereas 25mg/kg resulted in marked lethargy before 24h. Splenic interleukin-1β mRNA in BALB/c mice, and serum TNF-α concentrations in Wistar rats increased after LPS injection in a dose-dependent manner, but were undetectable in control animals, indicating that LPS had stimulated an inflammatory reaction. IL-1β and TNF-α concentrations in LPS-treated animals were unaffected by administration of a NOP antagonist. Similarly NOP antagonists had no effect on survival or expression of mRNA for NOP or ppN/OFQ (the N/OFQ precursor) in a variety of tissues. In these animal models, the dose-response curve for LPS was too steep to allow use in survival studies and no changes in the N/OFQ system occurred within 24h. We conclude that LPS-inoculation in rodents is an unsuitable model for studying possible changes in the NOP-N/OFQ system in sepsis.
AuthorsRoisin C Thomas, Michael F Bath, Cordula M Stover, David G Lambert, Jonathan P Thompson
JournalPeptides (Peptides) Vol. 61 Pg. 56-60 (Nov 2014) ISSN: 1873-5169 [Electronic] United States
PMID25161013 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • (Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)
  • Cycloheptanes
  • IL1B protein, mouse
  • Interleukin-1beta
  • Lipopolysaccharides
  • Opioid Peptides
  • Piperidines
  • Receptors, Opioid
  • Tumor Necrosis Factor-alpha
  • cis-1-methyl-7-((4-(2,6-dichlorophenyl)piperidin-1-yl)methyl)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol
  • nociceptin
  • Nociceptin Receptor
Topics
  • Animals
  • Cycloheptanes (pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Interleukin-1beta (metabolism)
  • Lipopolysaccharides (toxicity)
  • Mice
  • Mice, Inbred BALB C
  • Opioid Peptides (metabolism, pharmacology)
  • Piperidines (pharmacology)
  • Rats
  • Rats, Wistar
  • Receptors, Opioid (metabolism)
  • Sepsis (chemically induced, metabolism, pathology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Nociceptin Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: